Skip to main content

Latest SEC Filings — Page 67

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

First Busey Reports Strong Q1 Adjusted EPS Growth, NIM Expansion, and $65.6M Share Repurchase
ProForm 8-KBUSE · Form 8-K · 3d ago
Quantum Cyber N.V. Completes $6M Private Placement, Undergoes Change of Control and Board Overhaul
ProForm 8-KQUCY · Form 8-K · 3d ago
Updated Investor Presentation Reveals Going Concern Risk for Merger Target, Details $126.5M PIPE
ProForm 8-K/ALOKV · Form 8-K/A · 3d ago
Lunai Bioworks Postpones Special Meeting to May 8th to Secure Reverse Stock Split Vote Amid Delisting Threat
Form DEFA14ALNAI · Form DEFA14A · 3d ago
Citius Oncology Receives Nasdaq Delisting Warning for Sub-$1.00 Bid Price, Faces October Deadline
ProForm 8-KCTOR · Form 8-K · 3d ago
YY Group Relaunches $16.5M At-The-Market Offering, Signaling Massive Potential Dilution
ProForm 6-KYYGH · Form 6-K · 3d ago
LM Funding America Finalizes Shareholder Vote on Reverse Split to Avoid Delisting and Highly Dilutive Warrant Issuance
ProForm DEF 14ALMFA · Form DEF 14A · 3d ago
AerSale Files Definitive Proxy for Annual Meeting, Proposing Texas Redomestication
Form DEFA14AASLE · Form DEFA14A · 3d ago
NeoGenomics Reports Strong Q1 Results, Raises Full-Year Revenue Guidance, and Launches New Cancer Diagnostics
Form 8-KNEO · Form 8-K · 3d ago
Theravance Biopharma Details Strategic Review, Board Reduction, and Major Cost Cuts Following Drug Failure
ProForm DEF 14ATBPH · Form DEF 14A · 3d ago
Associated Banc-Corp Boosts Share Repurchase Authority to $214 Million, Elects New Director
ProForm 8-KASB · Form 8-K · 3d ago
AerSale Proposes Redomestication to Texas, Citing Legal Predictability and Officer Protections
Form DEF 14AASLE · Form DEF 14A · 3d ago
Scilex Commits $120M to Datavault AI for Quantum-Ready Network Amidst Going Concern Doubts
ProForm 8-KSCLX · Form 8-K · 3d ago
Vroom Details Over $55M in Critical Related Party Financing Post-Bankruptcy
ProForm DEF 14AVRM · Form DEF 14A · 3d ago
Republic Airways Finalizes CEO Succession Plan, Appoints Matthew Koscal as New CEO
Form 8-KRJET · Form 8-K · 3d ago
Secures $100K Promissory Note for Critical Compliance and Operations
Form 8-KTLSS · Form 8-K · 3d ago
Crypto Co Secures $25K Cash & BTC Private Placement, Issues 24M Shares and Prepaid Warrants
Form 8-KCRCW · Form 8-K · 3d ago
Tidewater Seeks Shareholder Approval for 2.25M Share Increase in Stock Incentive Plan
Form DEFA14ATDW · Form DEFA14A · 3d ago
Veritone Dismisses Auditor Amid Going Concern and Material Weaknesses
ProForm 8-KVERI · Form 8-K · 3d ago
CEO's Equity Award Cancelled Due to Plan Limits, Company Seeks Replacement
Form 8-KCVGI · Form 8-K · 3d ago
Devon Energy Details Post-Merger Leadership Structure for Combined Coterra Entity
Form 425DVN · Form 425 · 3d ago
Clean Energy Technologies Secures Highly Dilutive Convertible Note Amidst Nasdaq Delisting Threat
ProForm 8-KCETY · Form 8-K · 3d ago
RenaissanceRe Reports Strong Q1 2026 Operating Income and Substantial Share Repurchases
ProForm 8-KRNR · Form 8-K · 3d ago
Tidewater Seeks Shareholder Approval for 2.25M Share Incentive Plan Increase, Board Reduction
Form DEF 14ATDW · Form DEF 14A · 3d ago
Humacyte Seeks Shareholder Approval to Increase Authorized Shares by 200 Million, Paving Way for Future Capital Raises
ProForm DEF 14AHUMA · Form DEF 14A · 3d ago
Purple Innovation Reports Wider Q1 Loss, Reaffirms Going Concern Doubt, Extends Debt Maturity
ProForm 10-QPRPL · Form 10-Q · 3d ago
Aon plc Extends CEO Employment Through 2030, Grants $50M Special Equity Award
Form DEF 14AAON · Form DEF 14A · 3d ago
Kaiser Aluminum Seeks Shareholder Approval for New Equity Plan, Potentially Adding 2.4% Dilution
Form DEF 14AKALU · Form DEF 14A · 3d ago
Quad Reports Mixed Q1 Results with Sales Decline, Surging Net Debt, but Reaffirms 2026 Guidance
Form 8-KQUAD · Form 8-K · 3d ago
Anika Therapeutics Seeks Shareholder Approval for Significant Equity Plan Increases and Announces Board Reductions
Form DEF 14AANIK · Form DEF 14A · 3d ago